Clinical Trials Logo

Selenoprotein N-related Myopathy clinical trials

View clinical trials related to Selenoprotein N-related Myopathy.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02505087 Terminated - Clinical trials for Selenoprotein N-related Myopathy

Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)

SelNac
Start date: September 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to determine whether the administration of N-acetylcysteine (NAC) improves oxidative stress. To determine this, the study will assess the impact of oral treatment on the balance between reduced and oxidized form of glutathione in erythrocytes of peripheral blood.